Pulmatrix, Inc. (PULM) financial statements (2021 and earlier)

Company profile

Business Address 99 HAYDEN AVENUE
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments32233441910
Cash and cash equivalents32233441910
Receivables07 000 
Prepaid expense0000000
Deferred costs000001 
Other current assets      0
Other undisclosed current assets0000000
Total current assets:33313452011
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment0001110
Intangible assets, net (including goodwill)4411111123 
Goodwill4411111116 
Intangible assets, net (excluding goodwill)     8 
Restricted cash and investments000000 
Total noncurrent assets:65111212240
TOTAL ASSETS:38361516174511
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3333231
Accounts payable111011 
Accrued liabilities2322110
Employee-related liabilities      0
Other undisclosed accounts payable and accrued liabilities      0
Deferred revenue413
Debt01 331 
Other undisclosed current liabilities1      
Total current liabilities:81736541
Noncurrent Liabilities
Long-term debt and lease obligation1   36 
Long-term debt, excluding current maturities    36 
Operating lease, liability1 
Liabilities, other than long-term debt68 003 
Deferred revenue68
Deferred tax liabilities, net   3 
Derivative instruments and hedges, liabilities   000 
Total noncurrent liabilities:78 039 
Total liabilities:1525368121
Stockholders' equity
Stockholders' equity attributable to parent2311121093310
Common stock00 0000
Additional paid in capital25822620618416516120
Accumulated deficit(234)(215)(195)(174)(156)(128)(10)
Total stockholders' equity:2311121093310
TOTAL LIABILITIES AND EQUITY:38361516174511

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2015
Gross profit:1380011 
Operating expenses(22)(29)(20)(18)(26)(24)(7)
Operating loss:(10)(21)(20)(17)(25)(23)(7)
Nonoperating income (expense)(9)0(0)0(0)(0)0
Investment income, nonoperating00    0
Other nonoperating income (expense)(0)(0)00(0)(0) 
Interest and debt expense  (0)(1)(1)(1) 
Loss from continuing operations before equity method investments, income taxes:(19)(21)(21)(18)(26)(24)(7)
Other undisclosed income (loss) from continuing operations before income taxes   0(5)  
Loss from continuing operations before income taxes:(19)(21)(21)(18)(31)(24)(7)
Income tax benefit    3 4
Loss before gain (loss) on sale of properties:(19)(21)(21)(18)(28)(24)(3)
Other undisclosed net income  0    
Net loss:(19)(21)(21)(18)(28)(24)(3)
Other undisclosed net loss attributable to parent     (2)(4)
Net loss available to common stockholders, diluted:(19)(21)(21)(18)(28)(26)(7)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
3/31/2015
Net loss:(19)(21)(21)(18)(28)(24)(3)
Comprehensive loss, net of tax, attributable to parent:(19)(21)(21)(18)(28)(24)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: